Showing 381-390 of 450 results for "".
- Independent, Smaller Hospitals Will Need to Make Tough Choices to Survive COVID-19 Financial Crisis: Analysishttps://modernod.com/news/independent-smaller-hospitals-will-need-to-make-tough-choices-to-survive-covid-19-financial-crisis-analysis/2478252/Independent hospitals could need to make drastic decisions such as reducing service lines or workforces to survive the cash crisis caused by the COVID-19 pandemic, a new analysis finds, according to a FierceHealthcare
- Appeals Court Rules HHS Has Authority to Implement Site Neutral Payments, Dealing Blow to Hospitalshttps://modernod.com/news/appeals-court-rules-hhs-has-authority-to-implement-site-neutral-payments-dealing-blow-to-hospitals/2478041/A federal appeals court ruled Health and Human Services has the authority to cut Medicare payments to off-campus clinics to bring them in line with independent physician practices, reversing a lower court’s decision, according to a FierceHealthcare
- CMS Relaxes Rules to Boost Capacity of Providers as Facilities Tackle COVID-19 Outbreakhttps://modernod.com/news/cms-relaxes-rules-to-boost-capacity-of-providers-as-facilities-tackle-covid-19-outbreak/2477562/The Trump administration has relaxed rules to enable doctors to remotely care for patients across state lines at rural facilities and let nurse practitioners perform more duties as workforce capacity becomes a major concern, according to a FierceHealthcare
- CooperVision Shares Latest Contact Lens Research Results in Paper and Poster Presentations at Academy 2019https://modernod.com/news/coopervision-shares-latest-contact-lens-research-results-in-paper-and-poster-presentations-at-academy-2019/2477027/CooperVision clinicians and research partners are among the hundreds of presenters lined up to report their scientific advancements this week at Academy 2019 in Orlando. The latest company and company-sponsored research will be summarized in a series of papers and posters that encompass the compa
- Staar Surgical Announces FDA Approval of the Visian Toric ICL for the Correction of Myopia with Astigmatismhttps://modernod.com/news/staar-surgical-announces-fda-approval-of-the-visian-toric-icl-for-the-correction-of-myopia-with-astigmatism/2479890/Staar Surgical announced that the FDA has granted approval of the PMA supplement for the Visian Toric ICL for the correction of myopia with astigmatism. This approval represents an expansion of the Implantable Collamer Lens (ICL) product line for the correction of refractive error in patie
- Alcon Announces US Launch of Voyager DSLT for Glaucoma and Ocular Hypertensionhttps://modernod.com/news/alcon-announces-us-launch-of-voyager-dslt-for-glaucoma-and-ocular-hypertension/2482669/Alcon announced the full US commercial availability of Voyager DSLT, the first and only direct selective laser trabeculoplasty device (DSLT). According to Alcon, Voyager DSLT may accelerate the adoption of laser as a first-line therapy, making the treatment availabil
- Pixium Vision Announces the Launch of a Process to Find Buyershttps://modernod.com/news/pixium-vision-announces-the-launch-of-a-process-to-find-buyers/2481900/Pixium Vision SA announced that a tender process (appel d’offres) for the purpose of finding buyers to acquire the company's business will be published October 19. Unable to find financial investors within the restricted timeframe and in line with the company's n
- Bausch + Lomb Launches Lumify Eye Illuminations in the UShttps://modernod.com/news/bausch-lomb-launches-lumify-eye-illuminations-in-the-united-states/2481846/Bausch + Lomb announced the US launch of Lumify Eye Illuminations, a new line of hypoallergenic specialty eye care products developed to cleanse, nourish and brighten the sensitive eye area. “Many products contain chemicals or preservatives that can irritate the del
- Experimental Drug Inhibits or Prevents Diabetic Eye Disease in Wilmer Eye Institute Studyhttps://modernod.com/news/experimental-drug-inhibits-or-prevents-diabetic-eye-disease-in-wilmer-eye-institute-study/2481638/Researchers at Wilmer Eye Institute, Johns Hopkins Medicine say they have evidence that an experimental drug may prevent or slow vision loss in people with diabetes. The results are from a study that used mouse as well as human retinal organoids and eye cell lines. The team focused on m
- Heru Expands Wearable Platform with Launch of Dark Adaptationhttps://modernod.com/news/heru-expands-wearable-platform-with-launch-of-dark-adaptation-establishing-market-leading-amd-portfolio/2481090/Heru announced the launch of dark adaptation, the newest modality added to its wearable health and wellness platform’s vision screening line-up. Dark adaptation measures the eye’s ability to adjust from light to dark environments. Impaired dark adaptation may be one of the